Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the ERAS historical prices.
The 52 Week Low is $1.51 set on Fri, Dec 1, 2023.
The 52 Week High is $3.38 set on Mon, Jun 5, 2023. The current price, $1.89, is 0% below the 52 Week High.
The All-Time High is $24.34 set on Thu, Sep 2, 2021. The current price, $1.89, is 0% below the All Time High.
ERAS has no dividend history.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.